BioStar Capital

venture capital firm

Venture Capital United States
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
across known amounts
Stages

About

venture capital firm

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is BioStar Capital's primary investment focus?
BioStar Capital primarily invests in the Health Tech & Life Sciences sector, with all four of its recorded portfolio companies and investment rounds concentrated in this area.
Can you name some notable companies in BioStar Capital's portfolio?
Notable companies in BioStar Capital's portfolio include CathWorks, which raised $151.79M, and V-Wave, which raised $132.5M. For a full list, please refer to startupim.
What is BioStar Capital's typical investment amount range?
BioStar Capital's investment amounts range from $2M to $28M per round, according to startupim data.
Has BioStar Capital had any notable exits from its portfolio companies?
Yes, BioStar Capital has had two notable exits: CathWorks was acquired by Medtronic for $585M in February 2026, and V-Wave was acquired by Johnson & Johnson for $600M in August 2024.
What is BioStar Capital's activity as a lead investor?
According to startupim data, BioStar Capital has not acted as a lead investor in any of its recorded investment rounds.
When did BioStar Capital make its first recorded investment?
BioStar Capital made its first recorded investment in January 2013, in the company Angioslide.
What is the distribution of BioStar Capital's investment stages?
BioStar Capital's investments include two B Rounds, one D Round, and one Undisclosed stage round.
What was BioStar Capital's most recent investment activity?
BioStar Capital's most recent recorded investment activity was in October 2017, with an investment in CathWorks.